The efficacy and safety of omalizumab for a 3-year long course of treatment for severe hormone dependent allergic asthma

doi:10.3969/j.issn.1672-8467.2023.01.001

ZHU Gui-ping, CAI Hui, ZENG Ying-ying, GAO Xin, ZHU Meng-chan, YANG Cheng-yu, SONG Xi-xi, PENG Wen-jun, YE Ling, JIN Mei-ling

Fudan University Journal of Medical Sciences ›› 2023, Vol. 50 ›› Issue (01) : 1-7.

PDF(917 KB)

Fudan University Journal of Medical Sciences ›› 2023, Vol. 50 ›› Issue (01) : 1-7. DOI: 10.3969/j.issn.1672-8467.2023.01.001

Papers

The efficacy and safety of omalizumab for a 3-year long course of treatment for severe hormone dependent allergic asthma

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 50(01): 1-7 https://doi.org/10.3969/j.issn.1672-8467.2023.01.001

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(917 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2021-12-23	2023-01-30
Issue Date
2023-01-30

Please choose a citation manager

Content to export